Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 24, 2025Drug Development Research

Atopic Dermatitis: Updated Insights Into Pathophysiology and Emerging Therapies

View Full Paper
Ask AI
Bookmark
Share

Authors

MXMei XieLKLiang KongGLG Li

Discussion

Loading...

Member takes

Overview

Review highlights new therapies targeting IL-13 and IL-31 in atopic dermatitis, indicating significant improvements in patient management.

Key Points

  • Emerging therapies, including JAK inhibitors and biologics, improve treatment for atopic dermatitis.
  • Recent advancements in understanding the gut-skin axis highlight its role in atopic dermatitis pathophysiology.
  • Therapeutics targeting IL-13 and IL-31 demonstrate remarkable efficacy in reducing disease severity.
  • Individualized treatment strategies in atopic dermatitis may optimize therapeutic outcomes and patient management.

Cite This Study

Xie et al. (2025) studied this question.

synapsesocial.com/papers/68d6d8548b2b6861e4c3e4c6https://doi.org/10.1002/ddr.70161
View Full Paper
Ask AI
Bookmark
Share